Trial intelligence / Profile preview

Haloperidol vs Dexamethasone for PONV and Pain in Laparoscopy

NCT05246631Phase 4Completed

Sponsor
Universitas Indonesia
Start
Jan 2020
Primary completion
Mar 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of haloperidol in postoperative nausea and vomiting (PONV) and pain (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Postoperative Nausea and Vomiting at 24 hours. Started Jan 2020; status: completed.

02

Drugs

haloperidol
03

Conditions

postoperative nausea and vomiting (PONV)pain

Beyond the preview

Go deeper on NCT05246631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05246631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call